Validity of ICU Clinician's Appraisal of Proportionality in CPR
NCT ID: NCT07026773
Last Updated: 2025-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2025-05-18
2026-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chest Compression and Cerebral Oxygenation During Cardiopulmonary Resuscitation
NCT03062306
Outcomes and Risk Factors of CPR in PICU
NCT06300710
Perception of Inappropriate CPR: a Multicenter International Cross-sectional Survey
NCT02356029
Cerebral Oximetry and NIRS in Cardiac Arrest Patients
NCT03769740
Non-invasive Neurological Evaluation During CPR
NCT02684955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
At the ICU level, both physicians and nurses can have valuable insights into what the likely prognosis is of the OHCA patients they are treating. In subgroups with a poor prognosis (e.g. non-shockable unwitnessed arrest in older patient) the added value of the multimodal ICU neuroprognostication is potentially very limited or absent. The implication for intensive care could be that policy decisions could perhaps be made earlier in several situations. Exploring the prognostic value of the clinical perception of ICU physicians and ICU nurses regarding appropriateness of CPR and their prognostication of neurological outcome and quality of life relative to multimodal ICU neuroprognostication might help to refine the ethical guidance towards resuscitation decision making and towards ICU management after ROSC in general.
The study aims are:
1. To assess whether and to what extent the following factors are associated with ICU clinician's perception regarding appropriateness of CPR: perceived presence of frailty, poor quality of life and severe comorbidities, as well as objective factors related to the OHCA (shockable rhythm, bystander CPR, witnessed arrest) and clinician characteristics (age, gender, years of experience and professional background).
2. To assess the concordance between clinicians' combined perception of inappropriateness of CPR (i.e. whether or not at least 2 clinicians perceive CPR as inappropriate) and multimodal ICU neuroprognostication as performed in STEPCARE. The STEPCARE trial is an international, investigator-initiated, randomised trial on three different aspects of standard care after out-of-hospital cardiac arrest. In a 2x2x2 factorial design the effect of continuous sedation vs. minimal sedation, fever management with a device vs. without a device and a higher blood pressure target vs. a lower blood pressure target are compared. The primary outcome of the trial will be survival at 180 days with secondary outcomes including neurological function and health-related quality of life.
3. To investigate the prognostic value of clinicians' combined perception of inappropriateness of CPR, the clinician's prognostication (functional outcome and quality of life after 6 months) and the added prognostic value of the multimodal ICU neuroprognostication with regard to the long-term composite outcome (alive with a good functional outcome and good quality of life as defined in STEPCARE) above and beyond the prognostic value of clinicians' combined perception of inappropriateness of CPR and the clinician's prognostication within subgroups of initial non-shockable/shockable rhythm.
Statistical analysis Associations between the perception of ICU physicians and ICU nurses regarding appropriateness of CPR, on the one hand, and the ICU clinician's perceived presence of frailty, severe comorbidities, quality of life, as well as objective factors related to the OHCA (shockable rhythm, bystander CPR, witnessed arrest) and clinician characteristics (age, gender, years of experience and professional background), on the other hand, will be estimated (in terms of conditional odds ratios) using a generalised linear mixed effects model (with 'logit' link and a random intercept for center and for patient) to allow statistical inference (estimation of corresponding standard errors and confidence intervals) that correctly accounts for the multilevel structure of the data (i.e. clinicians clustered within patients, patients clustered within centers).
Subsequently, the concordance between clinicians' combined perception of inappropriateness of CPR (A) and the result of the multimodal ICU neuroprognostication (Y) will be assessed by estimating the following predictive metrics with Y being the outcome and A being the predictor:
* Positive Predictive Value (PPV)
* Negative Predictive Value (NPV)
* Sensitivity
* Specificity
* Area Under the Receiver-Operator Curve (AUC) The PPV expresses the percentage of poor multimodal ICU neuroprognostications among cases where at least two clinicians perceive CPR to have been inappropriate, while the NPV expresses the percentage of good multimodal ICU neuroprognostications among cases where less than two clinicians perceive CPR to have been inappropriate. Results of the multimodal ICU neuroprognostication will be imputed as 'good' or 'poor' whenever, respectively, patients were discharged alive or died before the multimodal ICU neuroprognostication could be conducted or completed. This enables calculation of the PPV and NPV in the population of patients originally included in the study and gives prospective insight into the extent to which clinicians' combined perception of inappropriateness of CPR in these patients is prognostic for the results of their multimodal ICU neuroprognostication. The sensitivity expresses the percentage of cases where at least two clinicians perceive CPR to have been inappropriate among poor multimodal ICU neuroprognostications, while the specificity expresses the percentage of cases where less than two clinicians perceive CPR to have been inappropriate among good multimodal ICU neuroprognostications. The latter two metrics will be calculated only in patients still hospitalized by the time the multimodal ICU neuroprognostication could be completed. This gives retrospective insight into the extent to which good or poor multimodal ICU neuroprognostication could already be anticipated by clinicians' combined perception of inappropriateness of CPR. Ideally, the multilevel nature of the data will be accounted for when estimating these metrics and their respective confidence intervals.
Subsequently, the prognostic value of clinicians' combined perception of inappropriate CPR and the clinician's prognostication with respect to the primary composite endpoint (alive with a good functional outcome and good quality of life as defined in STEPCARE) will be assessed in terms of the PPV, NPV and AUC. Additionally, the added or incremental prognostic value of the multimodal ICU neuroprognostication above and beyond that of ICU clinicians' combined perception of inappropriate CPR and the clinician's prognostication will be assessed in terms of increase in AUC. More specifically, two logistic regression model will be fitted: a logistic regression model for the primary outcome with clinicians' combined perception of inappropriate CPR, the clinician's prognostication as only predictor (model 1), and a logistic regression model for the primary outcome with clinicians' combined perception of inappropriate CPR, the clinician's prognostication and the result of the multimodal ICU neuroprognostication (and their interaction) as predictors (model 2). The AUCs of these models will be reported, as well as their respective PPV and NPV. AUC of model 2 minus AUC of model 1 will be estimated and used as a metric to quantify the added prognostic value. These analyses will be conducted for the entire study population, as well as in separate subgroups of patients with shockable versus non-shockable initial rhythms. For this analysis, whenever patients were discharged alive or died before the multimodal ICU neuroprognostication could be conducted or completed, results of the multimodal ICU neuroprognostication will be imputed in such a way that their coding is identical to that of the corresponding clinicians' combined perception of inappropriate CPR to reflect the fact that, in such cases, multimodal ICU neuroprognostication can by definition not have any added prognostic value. Ideally, the multilevel nature of the data will be accounted for when estimating these metrics and their respective confidence intervals.
The study will collect additional data apart from the STEPCARE study (NCT 05564754):
ICU doctors and nurses treating the patient in the first 24 hours after ICU admission are requested to complete a short (less than 3 minutes) survey, ideally as soon as possible since we are interested in the predictive value of clinical appraisal of the ICU doctor and ICU nurse.
The survey comprises questions regarding clinician characteristics, perception regarding frailty, quality of life, comorbidities, appropriateness of CPR and prognostication of the outcome 6 months after OHCA.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nurses and doctors working in Intensive Care Units
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University Innsbruck
Innsbruck, , Austria
Ziekenhuis Oost-Limburg
Genk, , Belgium
Ghent University Hospital
Ghent, , Belgium
Helsinki University Central Hospital
Helsinki, , Finland
Universitätsklinikum Lübeck
Lübeck, , Germany
Policlinico San Martino
Genova, , Italy
Wakefield Hospital
Wellington, , New Zealand
King Abdulaziz Medical City
Riyadh, , Saudi Arabia
Zürich University Hospital
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Information regarding STEPCARE study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ONZ-2025-0119
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.